Advertisement

Evaluating the Effectiveness of Human Papillomavirus Educational Intervention among Oral Health Professionals

  • Anubhuti Shukla
  • Joshua Nyambose
  • Rebecca Vanucci
  • Lisa Bennett Johnson
  • Kelly Welch
  • Eileen Lind
  • Alessandro Villa
Article

Abstract

This study aims to evaluate the effectiveness of an educational intervention that was designed to increase human papillomavirus (HPV) awareness and knowledge among oral health providers (OHPs). HPV educational lectures and a dental information toolkit on HPV were offered to OHPs in New England in 2016–2017. OHPs included dentists and dental hygienists. Post intervention surveys were distributed 1 month later. A total of 230 participants attended the educational lectures and received the toolkit. Descriptive statistics were used to compare the difference in knowledge and preparedness about HPV before and after the intervention. Eighty-nine OHPs completed the surveys. The response rate was 38.7%; however, for each question, the number of responses varied. Fifty-four (54%) (n = 26) of survey respondents were between 55 and 75 years of age with 73.5% (n = 36) being female and 55% (n = 45) working in private practice. Post intervention, 67.5% (n = 27) of the respondents felt more prepared, 82.6% (n = 38) reported clarity of their roles in educating their patients about HPV, and 91.6% (n = 44) reported an increase in knowledge about HPV. The HPV educational intervention was well received and successful at improving self-reported knowledge, comfort level, and preparedness of OHPs in discussing HPV with their patients. OHPs have the great opportunity to educate their patients about HPV and HPV vaccination. Further continuing education efforts may improve OHPs’ participation in HPV prevention.

Keywords

Human papilloma virus (HPV) Oropharyngeal cancer (OPC) Oral health professionals (OHP) 

Notes

Acknowledgements

The authors would like to thank Kevin Kiang and Akshay Keerthy who helped with data collection and distribution of surveys. Their efforts are greatly appreciated.

Supplementary material

13187_2018_1391_MOESM1_ESM.docx (23 kb)
ESM 1 (DOCX 22 kb)

References

  1. 1.
    McQuillan G, Kruszon-Moran D, Markowitz LE, Unger ER, Paulose-Ram R (2017) Prevalence of HPV in adults aged 18-69: United States, 2011-2014. NCHS Data Brief 280:1–8Google Scholar
  2. 2.
    Sonawane K, Suk R, Chiao EY, Chhatwal J, Qiu P, Wilkin T, Nyitray AG, Sikora AG, Deshmukh AA (2017) Oral human papillomavirus infection: differences in prevalence between sexes and concordance with genital human papillomavirus infection, NHANES 2011 to 2014. Ann Intern Med 167:714–724.  https://doi.org/10.7326/M17-1363 CrossRefPubMedGoogle Scholar
  3. 3.
    Shigeishi H, Sugiyama M (2016) Risk factors for oral human papillomavirus infection in healthy individuals: a systematic review and meta-analysis. J Clin Med Res 8(10):721–729.  https://doi.org/10.14740/jocmr2545w CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Lang Kuhs KA, Gonzalez P, Struijk L, Castro F, Hildesheim A, van Doorn LJ, Rodriguez AC, Schiffman M, Quint W, Lowy DR, Porras C, DelVecchio C, Katki HA, Jimenez S, Safaeian M, Schiller J, Solomon D, Wacholder S, Herrero R, Kreimer AR, Herrero R, Alfaro M, Bratti MC, Cortés B, Espinoza A, Estrada Y, Guillén D, Jiménez SE, Morales J, Villegas L, Morera LA, Porras C, Rodríguez AC, Hildesheim A, Kreimer AR, Lowy DR, Macklin N, Schiffman M, Schiller JT, Sherman M, Solomon D, Wacholder S, Freer E, Bonilla J, García-Piñeres A, Silva S, Atmella I, Ramírez M, Pinto L, Kemp T, Eklund C, Hutchinson M, Sidawy M, Quint W, van Doorn LJ, Struijk L (2013) Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica. J Infect Dis 208(10):1643–1652.  https://doi.org/10.1093/infdis/jit369 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Beachler DC, DʼSouza G (2013) Oral human papillomavirus infection and head and neck cancers in HIV-infected individuals. Curr Opin Oncol 25(5):503–510.  https://doi.org/10.1097/CCO.0b013e32836242b4 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Stenmark MH, Shumway D, Guo C, Vainshtein J, Mierzwa M, Jagsi R, Griggs JJ, Banerjee M (2017) Influence of human papillomavirus on the clinical presentation of oropharyngeal carcinoma in the United States. Laryngoscope 127(10):2270–2278.  https://doi.org/10.1002/lary.26566 CrossRefPubMedGoogle Scholar
  7. 7.
    Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, Copeland G, Cozen W, Peters ES, Huang Y, Saber MS, Altekruse S, Goodman MT, HPV Typing of Cancers Workgroup (2015) US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst 107(6):djv086.  https://doi.org/10.1093/jnci/djv086 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    CDC - HPV and oropharyngeal cancer Available at: https://www.cdc.gov/cancer/hpv/basic_info/hpv_oropharyngeal.htm. Accessed 23 Oct 2017.
  9. 9.
    CDC - HPV-associated cancer statistics Available at: https://www.cdc.gov/cancer/hpv/statistics/index.htm. Accessed 28 Oct 2017.
  10. 10.
    Cleveland JL, Junger ML, Saraiya M, Markowitz LE, Dunne EF, Epstein JB (2011) The connection between human papillomavirus and oropharyngeal squamous cell carcinomas in the United States: implications for dentistry. J Am Dent Assoc 142(8):915–924CrossRefPubMedGoogle Scholar
  11. 11.
    Elrefaey S, Massaro MA, Chiocca S, Chiesa F, Ansarin M (2014) HPV in oropharyngeal cancer: the basics to know in clinical practice. Acta Otorhinolaryngol Ital 34(5):299–309PubMedPubMedCentralGoogle Scholar
  12. 12.
    HPV/oral cancer facts—The Oral Cancer Foundation. Available at: http://oralcancerfoundation.org/understanding/hpv/hpv-oral-cancer-facts/. Accessed 16 Jan 2017.
  13. 13.
    Taberna M, Mena M, Pavón MA, Alemany L, Gillison ML, Mesía R (2017) Human papillomavirus-related oropharyngeal cancer. Ann Oncol 28(10):2386–2398.  https://doi.org/10.1093/annonc/mdx304 CrossRefPubMedGoogle Scholar
  14. 14.
    Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomark Prev 14(2):467–475.  https://doi.org/10.1158/1055-9965.EPI-04-0551 CrossRefGoogle Scholar
  15. 15.
    Castellsagué X, Alemany L, Quer M, Halec G, Quirós B, Tous S, Clavero O, Alòs L, Biegner T, Szafarowski T, Alejo M, Holzinger D, Cadena E, Claros E, Hall G, Laco J, Poljak M, Benevolo M, Kasamatsu E, Mehanna H, Ndiaye C, Guimerà N, Lloveras B, León X, Ruiz-Cabezas JC, Alvarado-Cabrero I, Kang CS, Oh JK, Garcia-Rojo M, Iljazovic E, Ajayi OF, Duarte F, Nessa A, Tinoco L, Duran-Padilla MA, Pirog EC, Viarheichyk H, Morales H, Costes V, Félix A, Germar MJ, Mena M, Ruacan A, Jain A, Mehrotra R, Goodman MT, Lombardi LE, Ferrera A, Malami S, Albanesi EI, Dabed P, Molina C, López-Revilla R, Mandys V, González ME, Velasco J, Bravo IG, Quint W, Pawlita M, Muñoz N, de Sanjosé S, Xavier Bosch F, ICO International HPV in Head and Neck Cancer Study Group (2016) HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J Natl Cancer Inst 108(6):djv403.  https://doi.org/10.1093/jnci/djv403 CrossRefPubMedGoogle Scholar
  16. 16.
    Saslow D, Andrews KS, Manassaram-Baptiste D, Loomer L, Lam KE, Fisher-Borne M, Smith RA, Fontham ETH, on behalf of the American Cancer Society Guideline Development Group (2016) Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsement. CA Cancer J Clin 66(5):375–385.  https://doi.org/10.3322/caac.21355 CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Brotherton JML, Bloem PN (2017) Population-based HPV vaccination programmes are safe and effective: 2017 update and the impetus for achieving better global coverage. Best Pract Res Clin Obstet Gynaecol 47:42–58.  https://doi.org/10.1016/j.bpobgyn.2017.08.010. CrossRefPubMedGoogle Scholar
  18. 18.
    Hirth JM, Chang M, Resto VA, HPV study group (2017) Prevalence of oral human papillomavirus by vaccination status among young adults (18-30 years old). Vaccine 35(27):3446–3451.  https://doi.org/10.1016/j.vaccine.2017.05.025. CrossRefPubMedGoogle Scholar
  19. 19.
    Gillison M, Xiao W Impact of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the U.S. J Clin Oncol 35(15_suppl)Google Scholar
  20. 20.
    Chaturvedi AK, Graubard BI, Broutian T, et al (2017) Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the united states. J Clin Oncol JCO2017750141.  https://doi.org/10.1200/JCO.2017.75.0141
  21. 21.
    Coan L, Windsor LJ, Romito LM (2015) Increasing tobacco intervention strategies by oral health practitioners in Indiana. J Dent Hyg 89(3):190–201PubMedGoogle Scholar
  22. 22.
    Jannat-Khah DP, McNeely J, Pereyra MR et al (2014) Dentists’ Self-Perceived Role in Offering Tobacco Cessation Services: Results From a Nationally Representative Survey, United States, 2010–2011. Prev Chronic Dis 11:E196.  https://doi.org/10.5888/pcd11.140186 CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Warnakulasuriya S (2002) Effectiveness of tobacco counseling in the dental office. J Dent Educ 66(9):1079–1087PubMedGoogle Scholar
  24. 24.
    Ciarrocca K, Jackson LL, De Rossi SS (2014) Human papillomavirus: the fundamentals of HPV for oral health care providers. Tex Dent J 131(5):366–374PubMedGoogle Scholar
  25. 25.
    Dentists detect diseases—Delta Dental. Available at: https://www.deltadentalins.com/oral_health/dentists-detect.html. Accessed 29 Oct 2017.
  26. 26.
    Daley E, DeBate R, Dodd V, Dyer K, Fuhrmann H, Helmy H, Smith SA (2011) Exploring awareness, attitudes, and perceived role among oral health providers regarding HPV-related oral cancers. J Public Health Dent 71(2):136–142CrossRefPubMedGoogle Scholar
  27. 27.
    Shepperd JA, Howell JL, Catalanotto F, Dodd VJ, Logan HL (2013) The decision to counsel adolescents about HPV. Am J Health Behav 37(6):755–762.  https://doi.org/10.5993/AJHB.37.6.4 CrossRefPubMedGoogle Scholar
  28. 28.
    Vázquez-Otero C, Vamos CA, Thompson EL, Merrell LK, Griner SB, Kline NS, Catalanotto FA, Giuliano AR, Daley EM (2017) Assessing dentists’ human papillomavirus-related health literacy for oropharyngeal cancer prevention. J Am Dent Assoc 149:9–17.  https://doi.org/10.1016/j.adaj.2017.08.021. CrossRefPubMedGoogle Scholar
  29. 29.
    Young JL, Bernheim RG, Korte JE, Stoler MH, Guterbock TM, Rice LW (2011) Human papillomavirus vaccination recommendation may be linked to reimbursement: a survey of Virginia family practitioners and gynecologists. J Pediatr Adolesc Gynecol 24(6):380–385.  https://doi.org/10.1016/j.jpag.2011.06.016 CrossRefPubMedGoogle Scholar
  30. 30.
    Eve S, Pham AD, Blaizot X, Turck M, Raginel T (2017) Human papillomaviruses vaccination: parental awareness and acceptance of the vaccine for children in lower Normandy schools and informative campaign during the 2015-2016 school year. Rev Epidemiol Sante Publique 65(4):255–263.  https://doi.org/10.1016/j.respe.2017.01.119. CrossRefPubMedGoogle Scholar
  31. 31.
    Yeganeh N, Curtis D, Kuo A (2010) Factors influencing HPV vaccination status in a Latino population; and parental attitudes towards vaccine mandates. Vaccine 28(25):4186–4191.  https://doi.org/10.1016/j.vaccine.2010.04.010 CrossRefPubMedGoogle Scholar
  32. 32.
    CDC recommends only two HPV shots for younger adolescentsError processing SSI file. Available at: https://www.cdc.gov/media/releases/2016/p1020-hpv-shots.html. Accessed 25 Oct 2017.
  33. 33.
    Lind E, Welch K, Perkins RB (2017) HPV-related cancer prevention through coalition building. Hum Vaccines Immunother 13(10):2300–2306.  https://doi.org/10.1080/21645515.2017.1338983 CrossRefGoogle Scholar
  34. 34.
    The Leading Research & Experience Software | Qualtrics. Available at: https://www.qualtrics.com/. Accessed 26 Jan 2018.
  35. 35.
    Survey exposes communication gap between providers/patients regarding HPV and cervical cancer. Available at: http://www.arhp.org/publications-and-resources/studies-and-surveys/hpv-survey. Accessed 29 Oct 2017.
  36. 36.
    Our Mission—the team—Team Maureen. Available at: http://www.teammaureen.org/about/theteam/c/10. Accessed 29 Oct 2017.
  37. 37.
    Daley E, Dodd V, DeBate R, Vamos C, Wheldon C, Kline N, Smith S, Chandler R, Dyer K, Helmy H, Driscoll A (2014) Prevention of HPV-related oral cancer: assessing dentists’ readiness. Public Health 128(3):231–238.  https://doi.org/10.1016/j.puhe.2013.12.002 CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Arora S, Ramachandra SS, Squier C (2017) Knowledge about human papillomavirus (HPV) related oral cancers among oral health professionals in university setting—a cross sectional study. J Oral Biol Craniofac Res 8:35–39.  https://doi.org/10.1016/j.jobcr.2017.12.002. CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Poelman MR, Brand HS, Forouzanfar T, Daley EM, Jager DHJ (2017) Prevention of HPV-related oral Cancer by dentists: assessing the opinion of Dutch dental students. J Cancer Educ.  https://doi.org/10.1007/s13187-017-1257-9
  40. 40.
    Liao P, Brown V (2014) Oral health and prevention and screening for HPV. Can Med Assoc J 186(17):1322–1322.  https://doi.org/10.1503/cmaj.114-0084 CrossRefGoogle Scholar
  41. 41.
    Hosking YP, Cappelli D, Donly K, Redding S (2017) HPV vaccination and the role of the pediatric dentist: survey of graduate program directors. Pediatr Dent 39(5):383–389PubMedGoogle Scholar
  42. 42.
    Daley EM, Thompson EL, Vamos CA, Griner SB, Vazquez-Otero C, Best AL, Kline NS, Merrell LK (2016) HPV-related knowledge among dentists and dental hygienists. J Cancer Educ.  https://doi.org/10.1007/s13187-016-1156-5
  43. 43.
    Association of State and Territorial Dental Directors (ASTDD), White Paper: Human Papilloma Virus (HPV) and Oropharyngeal Cancer, Adopted July 10, 2017, https://www.astdd.org/docs/hpv-opc-white-paper-July-2017.docx. Accessed 20 Mar 2018.

Copyright information

© American Association for Cancer Education 2018

Authors and Affiliations

  1. 1.Department of Oral Health Policy and EpidemiologyHarvard School of Dental MedicineBostonUSA
  2. 2.Bureau of Infectious Disease and Laboratory SciencesMassachusetts Department of Public HealthBostonUSA
  3. 3.Division of Oral Medicine and DentistryBrigham and Women’s HospitalBostonUSA
  4. 4.Team MaureenNorth FalmouthUSA
  5. 5.Division of Pediatric OncologyDana Farber Cancer CenterBostonUSA
  6. 6.Department of Oral Medicine, Infection and ImmunityHarvard School of Dental MedicineBostonUSA

Personalised recommendations